Dr.BUN-SK

Directions

Dr.BUN-SK Dr.BUN-SK ๐Ÿ‘จโ€โš•๏ธโค๏ธ๐Ÿฉบ๐Ÿ’Š๐Ÿ’‰Health and sharing

17/09/2026

๐Ÿ’‰ HOW TO CALCULATE INSULIN REQUIREMENT โ€” A SIMPLE STEPWISE GUIDE ๐Ÿฉบ๐Ÿง 

๐Ÿ“Œ Insulin therapy should always be individualized according to the patientโ€™s type of diabetes, body weight, glycaemic status, insulin sensitivity, renal function, and risk of hypoglycaemia.

๐Ÿ’ก Easy Formula:

Body Weight (kg) ร— Total Daily Dose (TDD) = Total Daily Insulin Requirement

---

1๏ธโƒฃ STEP 1: CALCULATE THE TOTAL DAILY DOSE (TDD)

๐Ÿ”ต TYPE 1 DIABETES MELLITUS

โ–ช๏ธ Typical starting dose: 0.4โ€“0.6 units/kg/day

โ–ช๏ธ Newly diagnosed / honeymoon phase: ~0.4 units/kg/day

โ–ช๏ธ Most adults: ~0.5 units/kg/day

โ–ช๏ธ Insulin-resistant patients may require 0.7โ€“1.0 units/kg/day

---

๐ŸŸข TYPE 2 DIABETES MELLITUS

Basal insulin initiation:

โ–ช๏ธ 10 units once daily
OR
โ–ช๏ธ 0.1โ€“0.2 units/kg/day

If a basalโ€“bolus regimen is required:

โ–ช๏ธ Start with 0.3โ€“0.5 units/kg/day

โ–ช๏ธ Some insulin-resistant patients may ultimately require 0.5โ€“1.0 units/kg/day

---

๐ŸŸฃ PREGNANCY โ€” GENERAL GUIDE

โ–ช๏ธ 1st trimester: ~0.7 units/kg/day

โ–ช๏ธ 2nd trimester: ~0.8 units/kg/day

โ–ช๏ธ 3rd trimester: ~0.9โ€“1.0 units/kg/day

โš ๏ธ Insulin requirements increase during pregnancy and should be individualized using SMBG/CGM and clinical monitoring.

---

2๏ธโƒฃ STEP 2: DIVIDE THE TOTAL DAILY DOSE

๐Ÿ”ท BASALโ€“BOLUS REGIMEN

40โ€“50% โ†’ BASAL INSULIN

โ–ช๏ธ Long-acting insulin
(e.g., glargine, degludec, detemir)

โฌ‡๏ธ

50โ€“60% โ†’ RAPID-ACTING (BOLUS) INSULIN

โ–ช๏ธ Divide initially before breakfast, lunch and dinner

โ–ช๏ธ Adjust according to glucose readings and meal patterns.

---

๐Ÿงฎ EXAMPLE 1 โ€” TYPE 1 DIABETES

Patient weight = 60 kg

TDD = 60 ร— 0.5 = 30 units/day

โžก๏ธ Basal insulin โ‰ˆ 15 units
โžก๏ธ Bolus insulin โ‰ˆ 15 units

Divide bolus:

๐Ÿณ Breakfast = 5 units
๐Ÿ› Lunch = 5 units
๐Ÿฝ๏ธ Dinner = 5 units

Initial regimen:

โ–ช๏ธ Basal insulin 15 units at bedtime
โ–ช๏ธ Rapid-acting insulin 5 units before each main meal

---

๐Ÿงฎ EXAMPLE 2 โ€” TYPE 2 DIABETES

Patient weight = 80 kg

Starting basal insulin:

0.2 ร— 80 = 16 units once daily

OR

Start with 10 units once daily and titrate according to fasting blood glucose.

---

3๏ธโƒฃ STEP 3: TITRATE THE DOSE

๐ŸŸฆ BASAL INSULIN

โœ… Increase by 2 units every 3 days
(or every 3โ€“7 days) until fasting glucose reaches the individualized target.

๐ŸŸช IF HYPOGLYCAEMIA OCCURS

โš ๏ธ Consider reducing the insulin dose by 10โ€“20% or more when clinically indicated.

๐Ÿ’ก Clinical Pearl:
If pre-lunch glucose is consistently high, adjust the breakfast bolus insulin rather than automatically increasing basal insulin.

---

๐ŸŽฏ GLYCAEMIC TARGETS โ€” MOST NON-PREGNANT ADULTS

๐Ÿ• Fasting glucose:
80โ€“130 mg/dL
(4.4โ€“7.2 mmol/L)

๐Ÿฝ๏ธ 1โ€“2 hour post-meal glucose:

16/09/2026
16/09/2026

๐Ÿฉบ MODIFIED SHOCK INDEX (MSI) โ€” A SIMPLE CLINICAL GUIDE ๐Ÿง 

๐Ÿ’ก Modified Shock Index (MSI) is a bedside tool that uses heart rate (HR) and mean arterial pressure (MAP) to help assess hemodynamic status and risk of deterioration, particularly in acutely ill patients.

๐Ÿ‘‰ Easy approach:

CALCULATE MAP โ†’ CALCULATE MSI โ†’ INTERPRET โ†’ CORRELATE CLINICALLY

โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”

1๏ธโƒฃ WHAT IS MODIFIED SHOCK INDEX?

๐Ÿ“Œ Formula

MSI = Heart Rate (HR) รท Mean Arterial Pressure (MAP)

Where:

๐Ÿ”ด HR = beats/min
๐Ÿ”ต MAP = mmHg

๐Ÿงฎ MAP Formula

MAP โ‰ˆ [SBP + (2 ร— DBP)] รท 3

โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”โ”

2๏ธโƒฃ ๐Ÿ“Š INTERPRETATION

๐ŸŸข MSI โ‰ˆ 0.7โ€“1.3
โ†’ Generally within the reference range in many clinical contexts.

๐ŸŸก MSI >1.3
โ†’ Suggests significant hemodynamic compromise.

๐Ÿ”ด MSI โ‰ฅ1.7
โ†’ Associated with increased risk of shock, ICU admission, and mortality in studied populations.

๐Ÿ”ต MSI

16/09/2026

Classification of Antibiotics: With Common Examples ๐Ÿงซ๐Ÿ’Š

Antibiotics are essential antimicrobial agents categorized into specific structural classes, each targeting distinct bacterial structures or metabolic pathways. Here is a high-yield clinical overview of the 15 major antibiotic classes and their practical applications:

1. Penicillins (\beta-lactams): Penicillin G, Penicillin V, Amoxicillin, Ampicillin, Cloxacillin, Dicloxacillin. Effective primarily against Gram-positive bacteria.
2. Cephalosporins (\beta-lactams): Cephalexin (1^{\text{st}} gen), Cefuroxime (2^{\text{nd}} gen), Ceftriaxone (3^{\text{rd}} gen), Cefepime (4^{\text{th}} gen), Ceftaroline (5^{\text{th}} gen). Broad-spectrum agents categorized by generation.
3. Carbapenems (\beta-lactams): Imipenem, Meropenem, Ertapenem. Ultra-broad-spectrum drugs reserved for multidrug-resistant infections.
4. Monobactams (\beta-lactams): Aztreonam. Active against Gram-negative aerobes; safe alternative for patients with \beta-lactam allergies.
5. Macrolides: Erythromycin, Azithromycin, Clarithromycin. Commonly targeted at atypical pathogens and respiratory tract infections.
6. Aminoglycosides: Gentamicin, Amikacin, Streptomycin, Tobramycin, Netilmicin. Bactericidal agents used for severe Gram-negative infections.
7. Tetracyclines: Tetracycline, Doxycycline, Minocycline. Broad-spectrum agents used for acne, respiratory, and rickettsial infections.
8. Fluoroquinolones: Ciprofloxacin, Levofloxacin, Ofloxacin, Moxifloxacin, Norfloxacin. Inhibit DNA gyrase/topoisomerase IV; widely used for UTIs and respiratory infections.
9. Sulfonamides: Co-trimoxazole (Trimethoprim + Sulfamethoxazole). Inhibit folic acid synthesis for UTIs and respiratory coverage.
10. Glycopeptides: Vancomycin, Teicoplanin. Effective against resistant Gram-positive organisms (e.g., MRSA).
11. Lincosamides: Clindamycin, Lincomycin. Active against anaerobic pathogens and Gram-positive cocci.
12. Oxazolidinones: Linezolid, Tedizolid. Protein synthesis inhibitors for resistant Gram-positive strains (e.g., MRSA, VRE).
13. Nitroimidazoles: Metronidazole, Tinidazole. Primary choice for anaerobic bacterial infections and protozoal conditions.
14. Polymyxins: Colistin (Polymyxin E), Polymyxin B. Membrane-disrupting agents reserved for multidrug-resistant Gram-negative bacteria.
15. Others: Chloramphenicol, Rifampicin, Nitrofurantoin, Fosfomycin. Site- and organism-specific niche agents.

Key Principles of Antibiotic Stewardship:
Choose antibiotics based strictly on pathogen identity, culture sensitivity, and infection site.

Ensure correct drug selection, precise dosing, and appropriate duration.
Avoid self-medication to prevent antimicrobial resistance.

Save this study card for quick clinical revision and share it with your healthcare peers! ๐Ÿ”–๐Ÿ“ฒ

16/09/2026

Comment on left Scrotal swelling ๐Ÿ˜ณ๐Ÿ˜ณ๐Ÿ˜ฒ
A 38-year-old male presented with left-sided scrotal swelling and pain for the past 5 days, associated with fever and local tenderness. The swelling had gradually increased in size, with discomfort during walking. There was no history of recent scrotal trauma or surgery. The patient was referred for scrotal ultrasound with color Doppler evaluation to assess the cause of acute scrotal swelling.



***um **is

15/09/2026
15/09/2026
14/09/2026

All these features are suggestive of โ“

14/09/2026

Address

Phnom Penh

Website

Alerts

Be the first to know and let us send you an email when Dr.BUN-SK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share